SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Cognition Studio, Inc.

Acalabrutinib MOA: A Novel Btk Inhibitor 

Prev Next
Previous

Btk Pathway in B Cell Close-Up

Next medical animation of Approximately 160 million people worldwide are infected with HCV and 60-80% of those people will develop a chronic infection. Cognition created this animation to illuminate the virus’ global health impact along with depicting the complex entry portion of its lifecycle. The assets were created and animated in Cinema 4D. Compositing and animated overlays were done in Adobe After Effects.

Hepatitis C Virus Life Cycle: Entry

Cognition covered all facets of ideation, development, and finessing of Acerta’s booth, materials, an interactive clinical trial experience, and MOA pre-clinical animation. Encased within a 12’ scale model of the monolith from Stanley Kubrick’s cult classic 2001: A Space Odyssey, the animation intended to transport the viewer through an immersive story environment of the ACP-196 MOA for the treatment of B-cell malignancies.

Keywords: Animation, 3D, Advertising / Marketing, Interactive, Allergy / Immunology, Biotechnology, Cell biology / Histology, Oncology, Mechanism of Action (MOA), Pathology

Acerta Pharma